14-24631153-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004131.6(GZMB):c.662G>A(p.Arg221Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,612,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004131.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GZMB | NM_004131.6 | c.662G>A | p.Arg221Gln | missense_variant | 5/5 | ENST00000216341.9 | NP_004122.2 | |
GZMB | NM_001346011.2 | c.626G>A | p.Arg209Gln | missense_variant | 5/5 | NP_001332940.1 | ||
GZMB | NR_144343.2 | n.556G>A | non_coding_transcript_exon_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GZMB | ENST00000216341.9 | c.662G>A | p.Arg221Gln | missense_variant | 5/5 | 1 | NM_004131.6 | ENSP00000216341 | P2 | |
ENST00000555300.1 | n.177+8027C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251386Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135864
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1460682Hom.: 0 Cov.: 30 AF XY: 0.0000303 AC XY: 22AN XY: 726734
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2023 | The c.662G>A (p.R221Q) alteration is located in exon 5 (coding exon 5) of the GZMB gene. This alteration results from a G to A substitution at nucleotide position 662, causing the arginine (R) at amino acid position 221 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at